openPR Logo
Press release

Metabolomics Market Size Worth USD 9.92 Billion in 2032 | Emergen Research

04-18-2024 04:02 PM CET | Health & Medicine

Press release from: Emergen Research

Metabolomics Market

Metabolomics Market

The global metabolomics market size was USD 2.58 Billion in 2022 and is expected to register a revenue CAGR of 14.6% during the forecast period. The global metabolomics market is experiencing significant growth, driven by various factors including the expansion of the healthcare industry, technological advancements, and increasing prevalence of chronic diseases. A recent market research report sheds light on the key drivers and insights shaping the metabolomics landscape.

Key Market Drivers:

1. Analytical Techniques: Metabolomics utilizes various analytical techniques such as spectroscopy, chromatography, and multivariate analysis, contributing to accurate determination of metabolites.
2. Prevalence of Chronic Diseases: Rising cases of chronic diseases globally, such as cardiovascular disorders and cancer, are fueling demand for advanced treatments and drug discovery, thereby boosting the metabolomics market.
3. Integration of AI, IoT, and ML: Technological advancements, including Artificial Intelligence (AI), Internet of Things (IoT), and Machine Learning (ML), are enhancing the efficiency and reliability of treatments, promising faster and more accurate procedures.
4. Revolutionary Breakthroughs in Technology: Innovative products launched by companies utilizing high-end technologies are driving market growth, with strategic measures like partnerships and new product launches further bolstering the landscape.

Get PDF Sample Report + All Related Table and Graphs @ https://www.emergenresearch.com/request-sample/2789

Market Restraints:
Despite the promising growth trajectory, challenges such as high costs associated with metabolomics instruments and data interpretation complexity restrain the market's revenue growth. Limited accessibility of advanced technologies in certain regions poses additional barriers to adoption.

Market Segmentation Insights:

1. Products & Services: The market is segmented into metabolomics instruments and metabolomics bioinformatics tools and services. While bioinformatics tools and services dominate the market, the instruments segment is expected to register the fastest growth during the forecast period.
2. Indications: Segments such as cancer and cardiovascular disorders hold significant market shares, driven by the increasing adoption of metabolomics in oncology and the rising prevalence of cardiovascular diseases globally.
3. End-Use: Academic and research institutes currently lead the market, with pharmaceutical and biotechnology companies anticipated to witness significant growth, driven by enhanced accessibility to treatment options.

Future Outlook:

With the healthcare industry's continued expansion, technological advancements, and increasing demand for personalized medicines, the metabolomics market is poised for robust growth in the coming years. Companies are expected to focus on innovation and strategic collaborations to capitalize on emerging opportunities.

Request a Discount on the Report @ https://www.emergenresearch.com/request-discount/2789

Metabolomics Top Companies and Competitive Landscape

The global metabolomics market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective Metabolomics solutions.

Some major players included in the global metabolomics market report are:

• Afekta Technologies Ltd.
• DNA Xperts Private Limited
• Metabolomic Technologies Inc.
• Agilent Technologies, Inc.
• MS-OMICS
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Shimadzu Corporation
• BASF SE
• Metabolon, Inc.

Metabolomics Latest Industry News

• In July 2021, Thermo Fisher Scientific Inc. and the University of California, Davis (UC Davis) launched the Center of Excellence in Clinical Metabolomics, a research collaboration to provide innovations, the best practices, and standard operating procedures to the metabolomics community.
• In December 2021, Dickinson and Company (BD) announced that "embecta" will be the name of the publicly traded company that will hold BD's Diabetes Care business.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2789

Metabolomics Market Segment Analysis

For the purpose of this report, Emergen Research has segmented global metabolomics market on the basis of products & services, application, indication, end-use, and region:

• Products & Services Outlook (Revenue, USD Billion; 2019-2032)
o Metabolomics instruments
o Metabolomics bioinformatics tools and services
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Drug discovery
o Biomarker discovery
o Nutrigenomics
o Functional genomics
o Personalized medicine
o Others
• Indication Outlook (Revenue, USD Billion; 2019-2032)
o Cancer
o Cardiovascular disorders
o Neurological disorders
o Others
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Academic and research institutes
o Contract research organizations
o Pharmaceutical and biotechnology companies
o Others
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. U.K.
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of MEA

To Visit Full Report & Table of Contents @ https://www.emergenresearch.com/industry-report/metabolomics-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolomics Market Size Worth USD 9.92 Billion in 2032 | Emergen Research here

News-ID: 3468940 • Views:

More Releases from Emergen Research

Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research
Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Publi …
The global Bacteriophage Market size was USD 43.52 Million in 2022 and is expected to register a steady revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of antibiotic-resistant bacteria and rising demand for personalized medicine and investments and research activities for the production of bacteriophage based treatments and medications are key factors driving market revenue growth. Bacteriophages have been shown to be
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | CAGR 23.6% - Published by Emergen Research
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | …
The global Internet of Behaviors (IoB) market size is expected to reach USD 3.087.86 Billion in 2032 and register a steady revenue CAGR of 23.6% over the forecast period, according to the latest analysis by Emergen Research. Stringent regulations on the use of Internet of Behaviors (IoB) in various industries and technological advancements of big data analytics and IoB technology are key factors driving market revenue growth. The use and
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 2032 | CAGR 13.9% - Published by Emergen Research
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 203 …
The global Consumer Internet of Things (IoT) Market size is expected to reach USD 334.78 Billion in 2032 and register a revenue CAGR of 13.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of smart devices and growing number of internet users is a major factor driving the market revenue growth. When using the Internet of Things for customer care, organizations can use the
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - Published by Emergen Research
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - P …
The Industrial Safety Market is experiencing robust growth, driven by the imperative need for workplace safety across various industries worldwide. Industrial safety encompasses a range of products, solutions, and services designed to protect workers, assets, and the environment from occupational hazards and accidents. With an increasing focus on compliance with stringent safety regulations, risk mitigation, and employee well-being, industries are investing in advanced safety technologies and practices. The market's expansion

All 5 Releases


More Releases for Metabolomic

Metabolomic Platform Market Research Outlook: 2022, Growth Estimation, New Techn …
The "Metabolomic Platform Market" Research Report is an intelligence report that has been meticulously compiled to research relevant and valuable information. The data studied is designed with both the best existing players and future competitors in mind. The key player's business strategy and new market industries are studied in detail. The report makes future forecasts based on an analysis of market segmentation, including product categories, end-user applications, and global Metabolomic
Metabolomics Services Market Growth and Major key players operating in the marke …
The research report " Global Metabolomics Services Market: By Service Type (Separation & Detection Services and Bioinformatics Services), Sample Type (Urine, Tumor, Cell Culture Media, Whole Blood, Food Ingredients, Feces), Sample Source (Human, Animal, Others), End-user (Healthcare Industry, Academic & Research Institutes, Food Processing Industry, Others), and Geography Global/Region/Country Forecast to 2027", The Global Metabolomics Services Market was valued at US$ 2.2 Bn in the year 2020 and is anticipated
Preeclampsia Diagnostics Market Analysis By COVID-19 Impact | Top Key Players: T …
Preeclampsia Diagnostics Market research report presents a comprehensive assessment of the Preeclampsia Diagnostics Market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. Preeclampsia Diagnostics Market Overview and the Impact of COVID-19 on the global Preeclampsia Diagnostics Market. Preeclampsia Diagnostics Market Research Report is an inestimable supply of perceptive information for business strategists. Major Key Players In Preeclampsia Diagnostics Market are Thermo Fisher Scientific Inc., Bayer
Breast Cancer Screening Market Size, Trends, Demand, Strategy to 2027 - A&G Phar …
Global Breast Cancer Screening Market valued approximately USD xxx million in 2017 is anticipated to grow with a healthy growth rate of more than xxx% over the forecast period 2018-2025. The Breast Cancer Screening market is developing and expanding at a significant pace considering the global scenario. The Breast cancer is considered as out of control growth of cells in the breast which could form a tumor or lump. These
Investment of Metabolomic Technologies to Drive Global Colorectal Cancer Screeni …
The stool-based test segment is expected to acquire a significant percentage of global colorectal cancer screening market share during the forecast period. This is because patients prefer it more due to its cost-effective nature and hassle-free procedure. It is hence, used the most as a primary screening test. This information is published in an upcoming report by Fortune Business Insights, titled, “Colorectal Cancer Screening Market Size, Share and Global Trend
Breast Cancer Screening Tests Market Set for Rapid Growth and Trend by 2023 | Gl …
Marketprognosis.com Publish a New Market Research Report On “Global Breast Cancer Screening Tests Market 2019 - 2023” which contains global key player’s survey information and forecast to 2023. Overview of the Global Breast Cancer Screening Tests Market: The report spread across 112 pages is an overview of the Global Breast Cancer Screening Tests Market. These report study based on the Breast Cancer Screening Tests Market. It is a complete overview of the